Chasing Novartis and Roche, Ventus banks $140M to take inflammatory disease drug into the clinic

Chasing Novartis and Roche, Ventus banks $140M to take inflammatory disease drug into the clinic

Source: 
Fierce Biotech
snippet: 

The money keeps flowing into Ventus Therapeutics. Just 10 months after raising one mega-round, the undruggable target specialist has banked a further $140 million as it prepares to file three INDs next year.